Carbetapentane tannate 30 mg / diphenhydramine tannate 25 mg / phenylephrine tannate 10 mg Extended Release Oral Tablet [Dytan-CS]
RxNorm 1297551
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1297551 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: carbetapentane tannate 30 mg / diphenhydramine tannate 25 mg / phenylephrine tannate 10 mg Extended Release Oral Tablet [Dytan-CS].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Carbetapentane tannate 30 mg / diphenhydramine tannate 25 mg / phenylephrine tannate 10 mg Extended Release Oral Tablet [Dytan-CS]
(Atom ID: 12369294)
TMSY
Tall Man Lettering Synonym (TMSY):
Carbetapentane tannate 30 mg / diphenhydrAMINE tannate 25 mg / phenylephrine tannate 10 mg Extended Release Oral Tablet [Dytan-CS]
(Atom ID: 12381103)
SY
Synonym (SY):
Dytan-CS (carbetapentane tannate 30 mg / diphenhydramine tannate 25 mg / phenylephrine tannate 10 mg) Extended Release Oral Tablet
(Atom ID: 6356004)
TMSY